These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 1385413)
1. Incorporation of type I collagen molecules that contain a mutant alpha 2(I) chain (Gly580-->Asp) into bone matrix in a lethal case of osteogenesis imperfecta. Niyibizi C; Bonadio J; Byers PH; Eyre DR J Biol Chem; 1992 Nov; 267(32):23108-12. PubMed ID: 1385413 [TBL] [Abstract][Full Text] [Related]
2. Lethal perinatal osteogenesis imperfecta due to a type I collagen alpha 2(I) Gly to Arg substitution detected by chemical cleavage of an mRNA:cDNA sequence mismatch. Bateman JF; Moeller I; Hannagan M; Chan D; Cole WG Hum Mutat; 1992; 1(1):55-62. PubMed ID: 1284475 [TBL] [Abstract][Full Text] [Related]
3. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the disease. Edwards MJ; Wenstrup RJ; Byers PH; Cohn DH Hum Mutat; 1992; 1(1):47-54. PubMed ID: 1301191 [TBL] [Abstract][Full Text] [Related]
4. Substitution of an aspartic acid for glycine 700 in the alpha 2(I) chain of type I collagen in a recurrent lethal type II osteogenesis imperfecta dramatically affects the mineralization of bone. Cohen-Solal L; Zylberberg L; Sangalli A; Gomez Lira M; Mottes M J Biol Chem; 1994 May; 269(20):14751-8. PubMed ID: 8182080 [TBL] [Abstract][Full Text] [Related]
5. An alpha2(I) glycine to aspartate substitution is responsible for the presence of a kink in type I collagen in a lethal case of osteogenesis imperfecta. Forlino A; Keene DR; Schmidt K; Marini JC Matrix Biol; 1998 Dec; 17(8-9):575-84. PubMed ID: 9923651 [TBL] [Abstract][Full Text] [Related]
6. Lethal perinatal osteogenesis imperfecta due to the substitution of arginine for glycine at residue 391 of the alpha 1(I) chain of type I collagen. Bateman JF; Chan D; Walker ID; Rogers JG; Cole WG J Biol Chem; 1987 May; 262(15):7021-7. PubMed ID: 3108247 [TBL] [Abstract][Full Text] [Related]
7. Substitution of arginine for glycine 664 in the collagen alpha 1(I) chain in lethal perinatal osteogenesis imperfecta. Demonstration of the peptide defect by in vitro expression of the mutant cDNA. Bateman JF; Lamande SR; Dahl HH; Chan D; Cole WG J Biol Chem; 1988 Aug; 263(24):11627-30. PubMed ID: 3403550 [TBL] [Abstract][Full Text] [Related]
8. Lethal osteogenesis imperfecta with amniotic band lesions: collagen studies. van der Rest M; Hayes A; Marie P; Desbarats M; Kaplan P; Glorieux FH Am J Med Genet; 1986 Jul; 24(3):433-46. PubMed ID: 3728562 [TBL] [Abstract][Full Text] [Related]
9. Substitutions of aspartic acid for glycine-220 and of arginine for glycine-664 in the triple helix of the pro alpha 1(I) chain of type I procollagen produce lethal osteogenesis imperfecta and disrupt the ability of collagen fibrils to incorporate crystalline hydroxyapatite. Culbert AA; Lowe MP; Atkinson M; Byers PH; Wallis GA; Kadler KE Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):815-20. PubMed ID: 7487936 [TBL] [Abstract][Full Text] [Related]
10. Serine for glycine substitutions in type I collagen in two cases of type IV osteogenesis imperfecta (OI). Additional evidence for a regional model of OI pathophysiology. Marini JC; Lewis MB; Wang Q; Chen KJ; Orrison BM J Biol Chem; 1993 Feb; 268(4):2667-73. PubMed ID: 8094076 [TBL] [Abstract][Full Text] [Related]
11. Two additional cases of osteogenesis imperfecta with substitutions for glycine in the alpha 2(I) collagen chain. A regional model relating mutation location with phenotype. Wang Q; Orrison BM; Marini JC J Biol Chem; 1993 Nov; 268(33):25162-7. PubMed ID: 7693712 [TBL] [Abstract][Full Text] [Related]
12. Multiexon deletions in the type I collagen COL1A2 gene in osteogenesis imperfecta type IB. Molecules containing the shortened alpha2(I) chains show differential incorporation into the bone and skin extracellular matrix. Mundlos S; Chan D; Weng YM; Sillence DO; Cole WG; Bateman JF J Biol Chem; 1996 Aug; 271(35):21068-74. PubMed ID: 8702873 [TBL] [Abstract][Full Text] [Related]
13. Type I procollagens containing substitutions of aspartate, arginine, and cysteine for glycine in the pro alpha 1 (I) chain are cleaved slowly by N-proteinase, but only the cysteine substitution introduces a kink in the molecule. Lightfoot SJ; Holmes DF; Brass A; Grant ME; Byers PH; Kadler KE J Biol Chem; 1992 Dec; 267(35):25521-8. PubMed ID: 1460046 [TBL] [Abstract][Full Text] [Related]
14. Osteogenesis imperfecta type IV. Detection of a point mutation in one alpha 1(I) collagen allele (COL1A1) by RNA/RNA hybrid analysis. Marini JC; Grange DK; Gottesman GS; Lewis MB; Koeplin DA J Biol Chem; 1989 Jul; 264(20):11893-900. PubMed ID: 2745420 [TBL] [Abstract][Full Text] [Related]
15. Osteogenesis imperfecta. The position of substitution for glycine by cysteine in the triple helical domain of the pro alpha 1(I) chains of type I collagen determines the clinical phenotype. Starman BJ; Eyre D; Charbonneau H; Harrylock M; Weis MA; Weiss L; Graham JM; Byers PH J Clin Invest; 1989 Oct; 84(4):1206-14. PubMed ID: 2794057 [TBL] [Abstract][Full Text] [Related]
16. The substitution of arginine for glycine 85 of the alpha 1(I) procollagen chain results in mild osteogenesis imperfecta. The mutation provides direct evidence for three discrete domains of cooperative melting of intact type I collagen. Deak SB; Scholz PM; Amenta PS; Constantinou CD; Levi-Minzi SA; Gonzalez-Lavin L; Mackenzie JW J Biol Chem; 1991 Nov; 266(32):21827-32. PubMed ID: 1718984 [TBL] [Abstract][Full Text] [Related]
17. Frameshift mutation near the 3' end of the COL1A1 gene of type I collagen predicts an elongated Pro alpha 1(I) chain and results in osteogenesis imperfecta type I. Willing MC; Cohn DH; Byers PH J Clin Invest; 1990 Jan; 85(1):282-90. PubMed ID: 2295701 [TBL] [Abstract][Full Text] [Related]
18. Severity of osteogenesis imperfecta and structure of a collagen-like peptide modeling a lethal mutation site. Radmer RJ; Klein TE Biochemistry; 2004 May; 43(18):5314-23. PubMed ID: 15122897 [TBL] [Abstract][Full Text] [Related]
19. Intron-mediated recombination may cause a deletion in an alpha 1 type I collagen chain in a lethal form of osteogenesis imperfecta. Barsh GS; Roush CL; Bonadio J; Byers PH; Gelinas RE Proc Natl Acad Sci U S A; 1985 May; 82(9):2870-4. PubMed ID: 3857621 [TBL] [Abstract][Full Text] [Related]
20. G76E substitution in type I collagen is the first nonlethal glutamic acid substitution in the alpha1(I) chain and alters folding of the N-terminal end of the helix. Cabral WA; Chernoff EJ; Marini JC Mol Genet Metab; 2001 Apr; 72(4):326-35. PubMed ID: 11286507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]